INDICACIONES PARA TROMBOLISIS PDF

Based on studies on solubility, bioequivalence and therapeutic equivalence, the present recomendations are based on evidence obtained using original drugs. El tratamiento anticoagulante debe ser utilizado por facultativos adecuadamente preparados para el manejo de los procesos de ETE. En la siguiente tabla se describen los criterios de elegibilidad y contraindicaciones. R: I; NE: A Existen pocas evidencias en la literatura, respecto a las opciones disponibles.

Author:Douzragore Nekazahn
Country:Turks & Caicos Islands
Language:English (Spanish)
Genre:Automotive
Published (Last):8 July 2004
Pages:243
PDF File Size:4.77 Mb
ePub File Size:7.56 Mb
ISBN:664-5-82990-683-9
Downloads:31100
Price:Free* [*Free Regsitration Required]
Uploader:Gonris



Based on studies on solubility, bioequivalence and therapeutic equivalence, the present recomendations are based on evidence obtained using original drugs. El tratamiento anticoagulante debe ser utilizado por facultativos adecuadamente preparados para el manejo de los procesos de ETE. En la siguiente tabla se describen los criterios de elegibilidad y contraindicaciones. R: I; NE: A Existen pocas evidencias en la literatura, respecto a las opciones disponibles. Local low-dose thrombolytic therapy of peripheral arterial occlusions.

N Engl J Med ; Fibrinolysis in chronic arteriosclerotic occlusions: intrathrombotic injections of streptokinase. Radiology ; Intraarterial thrombolysis: long-term results. Radiology ; Intra-arterial fibrinolysis: in vitro and prospective clinical evaluation of three fibrinolytic agents. Peripheral arterial occlusions: a 6-year experience with local low-dose thrombolytic therapy. Randomized trial of intra-arterial recombinant tissue plasminogen activator, intravenous plasminogen activator and intra-arterial streptokinase in peripheral arterial thrombolysis.

Br J Surg ; Limitations to the widespread usage of low-dose intra-arterial thrombolysis. Eur J Vasc Surg ;5: Low-dose intra-arterial thrombolysis in the treatment of occluded vascular grafts. Br J Surg ; Choice of agent for peripheral thrombolysis. Long-term results of a single protocol for thrombolysis in acute lower limb ischaemia. Eur J Vasc Surg ; Intra-arterial thrombolytic therapy in the management of acute and chronic limb ischaemia.

Effect of local urokinase on arterial occlusion of lower limbs. Thromb Haemost ; Complications of intraarterial urokinase-lys-plasminogen infusion therapy in arterial ischemia of lower limbs. Am J Roentengenol ; Local thrombolysis in peripheral arteries and bypass grafts. J Vasc Surg ; In situ thrombolysis for late occlusion of suprafemoral prosthetic grafts.

Ann Vasc Surg ; Continuous postoperative intra-arterial urokinase infusion in the treatment of no reflow following revascularization of the acutely ischemic limb. Local thrombolytic therapy of peripheral arterial ischaemia with tissue plasminogen activator: a dose ranging study. Recombinant tissue-type plasminogen activator is superior to streptokinase for local intra-arteral thrombolysis.

Intra-arterial thrombolysis using recombinant tissue plasminogen activator rt-PA : the optimal agant. Local thrombolysis for occluded arterial grafts: is the yield worth the effort?

J Cardiovasc Surg ; Femoro-popliteal artery thrombolysis with intra-arterial infusion of recombinant tissue-type plasminogen activator—Report of a pilot trial. Astedt B, Norgren L, Surgical treatment versus thrombolysis in acute arterial occlusion: a randomized controlled study.

Recombinant human tissue-type plasminogen activator is an effective agent for thrombolysis of peripheral arteries and bypass grafts: preliminary report. J Vasc Surg ; Results of a prospective randomised trial evaluating surgery versus thrombolysis for ischaemia of the lower extremity.

Ann Surg ; Grossbard EB. Thrombolysis with recombinant human tissue-type plasminogen activator in patients with peripheral arterial disease. Circulation ;74 Suppl 1 :1— Thrombolytic therapy with recombinant human tissue type plasminogen activator: a comparison of two doses. Thrombolysis of peripheral arterial and graft occlusions: improved results using high-dose urokinase.

Am J Roentgenol ; A reevaluation of intraarterial thrombolytic therapy for acute lower extremity ischemia. A comparison of thrombolytic therapy with operative vascularization in the initial treatment of acute peripheral arterial ischemia. Acceleration of thrombolysis with a high-dose transthrombus bolus technique. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial.

Complications of transluminal angioplasty. Outcome of intra-arterial urokinase for acute arterial occlusion. A new intra-arterial rt-PA dosage regimen in peripheral arterial occlusion: bolus followed by continuous infusion. Thromb Haemost ; Accelerated thrombolysis using pulsed intra-thrombus recombinant tissue type plasminogen activator. Experience with pulse-spray technique in peripheral thrombolysis. Eur J Vasc Surg ; Occluded peripheral arteries and bypass grafts: lytic stagnation as an endpoint for pulse-spray pharmacomechanical thrombolysis.

Internist ; Intraarterial thrombolysis of lower extremity occlusion: prospective randomized comparison of forced periodic infusion and conventional slow continuous infusion. Intra-operative, intra-arterial thrombolytic therapy for salvage of limbs in patients with distal arterial thrombosis.

Surg Gynecol Obstet ; Intra-operative fibrinolytic therapy in acute arterial occlusion. Intra-operative streptokinase: a useful adjunct to balloon catheter embolectomy. Riggs P, Ouriel K. Thrombolysis in the treatment of lower extremity occlusive disease.

Surg Clin N Am ; Intraoperative fibrinolytic therapy for salvage of limbs with acute arterial surgery: an adjunct to thromboembolectomy. Intraoperative catheter thrombolysis as an adjunct to surgical revascularisation for infrainguinal limb-threatening ischaemia. El tratamiento debe contemplar tanto el uso de antiagretantes plaquetarios, como la necesidad de minimizar los factores de riesgo cardiovasculares modificables.

Trauma significativo facial o cercano al cerebro en los 3 meses previos. R: I; NE: B R: I; NE: C. La ICP primaria debe ser realizada tan pronto como sea posible, idealmente en los primeros 90 minutos de contacto con el equipo de salud. R: I; NE: A. R: I: NE: B R: I; NE: C El uso de antiplaquetarios en pacientes con trombosis intracavitaria no ha sido estudiado extensamente.

Intraoperative use of thrombolytic agents. Br Med J ; Earnshaw JJ, Birch P. Peripheral thrombolysis: state of the art. Cardiovasc Surg ; Mantenimiento: aspirina No usar de rutina anticoagulantes. Procedimientos endovasculares en miembros inferiores angioplastia.

AN INTRODUCTION TO POLITICAL THEORY O P GAUBA PDF

Enfermedad arterial periférica (PAD)

Slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our User Agreement and Privacy Policy. See our Privacy Policy and User Agreement for details. Published on Apr 11, SlideShare Explore Search You.

ABAQUS 6.10 TUTORIALS PDF

Tromboembolismo pulmonar masivo de alto riesgo asociado a foramen oval permeable High-risk massive pulmonary thromboembolism associated with patent foramen ovale. Directory of Open Access Journals Sweden. High mortality rate associated with massive pulmonary embolism requires an aggressive invasive approach including surgical pulmonary embolectomy when thrombolytic therapy has failed or is contraindicated. We describe a case of high-risk massive pulmonary embolism who underwent surgical treatment due to the presence of a mobile intracardiac clot in a patent foramen ovale , and the possible risk of paradoxical arterial embolism.

FOLLOWING THE NOTES PIA EHRHARDT PDF

Acute basilar artery thrombosis ABT has been largely considered a neurological catastrophe. An early presumptive diagnosis is essential to avoid treatment delay. Either multiparametric magnetic resonance imaging or computed tomography angiography source images may represent valid non-invasive tools to confirm ABT and evaluate ischemic tissue viability.. The main determinant of ABT outcome is early recanalization but the most effective therapeutic option remains to be clarified. Therefore, in the absence of contraindications, intravenous thrombolysis should be started as soon as possible and can be used as the main therapy when interventional procedures are not available. These results represent a hope for patients and neurologists and reinforce the need for innovation and research in this field..

ALBERTO MARIO BANTI IL RISORGIMENTO ITALIANO PDF

.

Related Articles